Literature DB >> 4614899

Adriamycin (NSC-123127) in combination with cyclophosphamide (NSC-26271): a phase I and II evaluation.

F M Muggia, M Perloff, G A Chia, L J Reed, G C Escher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4614899

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN： 0069-0112


× No keyword cloud information.
  4 in total

1.  Effect of cyclophosphamide pretreatment on the short-term disposition and biliary excretion of adriamycin metabolites in rat.

Authors:  N Hartman; P J Basseches; G Powis
Journal:  Cancer Chemother Pharmacol       Date:  1982-12       Impact factor: 3.333

2.  Proceedings: The nitrosation of food amines under stomach conditions.

Authors:  C S Dyke; C L Walters
Journal:  Br J Cancer       Date:  1975-08       Impact factor: 7.640

3.  Adriamycin/cyclophosphamide and adriamycin/melphalan in advanced L1210 leukaemia.

Authors:  J S Tobias; L M Parker; M H Tattersall; E Frei
Journal:  Br J Cancer       Date:  1975-08       Impact factor: 7.640

Review 4.  Achievements of cancer chemotherapy.

Authors:  J S Tobias; J M Whitehouse
Journal:  J R Coll Physicians Lond       Date:  1976-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.